Fundraising Fox
Zura Bio
NASDAQ: ZURALa Jolla, US · Founded 2021 · 2 known investors
Find your way into Zura Bio
Sign up to see every warm intro you have to Zura Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zura Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Zura Bio is a clinical-stage biotechnology company developing antibody therapies for autoimmune diseases using a dual antagonism strategy that targets multiple immune pathways simultaneously. Its pipeline includes in-licensed assets such as tibulizumab, crebankitug, and torudokimab, advancing through Phase 2 trials for conditions like systemic sclerosis and hidradenitis suppurativa.
Founders & leadership
Zura Bio was founded in 2021 by Someit Sidhu.
KN
Kiran NistalaChief Medical Officer and Head of DevelopmentKiran Nistala is Chief Medical Officer and Head of Development at Zura Bio, a clinical-stage biotech company developing antibody therapies for autoimmune diseases. He is a clinician scientist and pharmaceutical physician with expertise in immunology and translational medicine.
NG
Neil GrahamNamed on SEC filing
GW
Gary WhaleChief Technology Officer
GN
Garry NeilNamed on SEC filing
MH
Michael HowellNamed on SEC filing
CC
Christopher CabellNamed on SEC filing
AM
Amit MunshiNamed on SEC filing
VB
Verender BadialNamed on SEC filing
JJ
Jennifer JarrettNamed on SEC filing
SS
Steven SchochNamed on SEC filing
Investors · 2
Funding
SEC filings, press & company announcements$128.4M disclosed across 2 of 4 rounds · 2023–2026
- Undisclosed amountpublic offeringFeb 2026Source ↗
▶$112.5MraisedMay 2024 · 19 investors · BiotechnologyRule 506(b)
▶$112.5MraisedMay 2024 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HowellExecutive Officer
- Sandeep KulkarniDirector
- Robert LisickiExecutive Officer, Director
- Neil GrahamDirector
- Kiran NistalaExecutive Officer
- Gary WhaleExecutive Officer
- Verender BadialExecutive Officer
- Steven SchochDirector
- Jennifer JarrettDirector
- Someit SidhuDirector
- Amit MunshiDirector
- Kim DavisExecutive Officer
- Arnout Ploos van AmstelDirector
- Parvinder ThiaraDirector
- Offering amount
- $112.5M
- Amount sold
- $112.5M
- Finders' fees
- $6.8M
- First sale
- Apr 2024
- Incorporated
- Corporation, Cayman Islands, 2021
- Federal exemptions
- 06b
▶$15.9MraisedMay 2023 · 21 investors · BiotechnologyRule 506(b)
▶$15.9MraisedMay 2023 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Neil GrahamDirector
- Gary WhaleExecutive Officer
- Garry NeilDirector
- Michael HowellExecutive Officer
- Christopher CabellExecutive Officer
- Amit MunshiDirector
- Verender BadialExecutive Officer
- Jennifer JarrettDirector
- Steven SchochDirector
- Someit SidhuExecutive Officer, Director
- Kim DavisExecutive Officer
- Sandeep KulkarniDirector
- Offering amount
- $80M
- Amount sold
- $15.9M
- Sales commissions
- $2.4M
- First sale
- May 2023
- Incorporated
- Corporation, Cayman Islands, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 7
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
TipRanksFinancial analysis and stock research platform.
PublicPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Companies working in the same space as Zura Bio.
Frequently asked questions
- What does Zura Bio do?
- Zura Bio is a clinical-stage biotechnology company developing antibody therapies for autoimmune diseases using a dual antagonism strategy that targets multiple immune pathways simultaneously. Its pipeline includes in-licensed assets such as tibulizumab, crebankitug, and torudokimab, advancing through Phase 2 trials for conditions like systemic sclerosis and hidradenitis suppurativa.
- Who founded Zura Bio?
- Zura Bio was founded by Someit Sidhu in 2021.
- Who are Zura Bio's investors?
- Zura Bio's investors include Access Biotechnology, TMG Ventures.
- How much funding has Zura Bio raised?
- Zura Bio has disclosed $128.4M raised across 2 of its 4 known rounds.
- Where is Zura Bio headquartered?
- Zura Bio is headquartered in La Jolla, US.